Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer (Q32073515)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer |
scientific article |
Statements
1 reference
Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer (English)
1 reference
G Batist
1 reference
G Ramakrishnan
1 reference
C S Rao
1 reference
A Chandrasekharan
1 reference
J Gutheil
1 reference
T Guthrie
1 reference
P Shah
1 reference
A Khojasteh
1 reference
M K Nair
1 reference
K Hoelzer
1 reference
K Tkaczuk
1 reference
Y C Park
1 reference
L W Lee
1 reference
1 reference
Identifiers
1 reference